A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Greece- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Greece39 clinical trials in Cholargos, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
GreeceThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), including investigations of targeted therapies and immunotherapy combinations.
Research focuses on improving survival rates and treatment effectiveness for patients with various stages of lung cancer.
Innovative clinical trials examining treatments for HER2-positive and estrogen receptor-positive breast cancer, with particular attention to early-stage and metastatic conditions.
Studies aim to enhance treatment outcomes and reduce recurrence risks in breast cancer patients.
Advanced research into bladder cancer and metastatic prostate cancer, exploring innovative combination therapies and novel treatment approaches.
Trials focus on improving treatment outcomes for patients with advanced urological malignancies.
Studies investigating treatments for advanced colorectal cancer, particularly focusing on specific genetic mutations and targeted therapies.
Research aims to develop personalized treatment approaches based on genetic profiles.
Tell us about your condition – we search every trial in Europe and connect you with the right site.